Hadasit Bio-Holdings Ltd
HBL - Hadasit Bio-Holdings Ltd operates in the biotechnology industry in Israel. It operates in the fields of oncology, regenerative medicine, and inflammatory disease. The company develops biological drugs; and plasma RNA biomarkers for colorectal cancer. It offers ProtAb, an immunotherapeutic monoclonal antibody for the treatment of autoimmune inflammatory diseases. HBL - Hadasit Bio-Holdings L… Read more
Hadasit Bio-Holdings Ltd (HSITF) - Total Assets
Latest total assets as of June 2024: $5.57 Million USD
Based on the latest financial reports, Hadasit Bio-Holdings Ltd (HSITF) holds total assets worth $5.57 Million USD as of June 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Hadasit Bio-Holdings Ltd - Total Assets Trend (2012–2023)
This chart illustrates how Hadasit Bio-Holdings Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Hadasit Bio-Holdings Ltd - Asset Composition Analysis
Current Asset Composition (December 2023)
Hadasit Bio-Holdings Ltd's total assets of $5.57 Million consist of 100.0% current assets and 0.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 5.6% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2012–2023)
This chart illustrates how Hadasit Bio-Holdings Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Hadasit Bio-Holdings Ltd's current assets represent 100.0% of total assets in 2023, an increase from 63.1% in 2012.
- Cash Position: Cash and equivalents constituted 5.6% of total assets in 2023, down from 33.7% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 3.0% in 2012.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
Hadasit Bio-Holdings Ltd Competitors by Total Assets
Key competitors of Hadasit Bio-Holdings Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Hadasit Bio-Holdings Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Hadasit Bio-Holdings Ltd generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Hadasit Bio-Holdings Ltd is currently not profitable relative to its asset base.
Hadasit Bio-Holdings Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.51 | 4.93 | 0.89 |
| Quick Ratio | 2.51 | 4.93 | 0.89 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $3.35 Million | $ 8.58 Million | $ -443.00 |
Hadasit Bio-Holdings Ltd - Advanced Valuation Insights
This section examines the relationship between Hadasit Bio-Holdings Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.75 |
| Latest Market Cap to Assets Ratio | 0.04 |
| Asset Growth Rate (YoY) | -79.3% |
| Total Assets | $8.06 Million |
| Market Capitalization | $345.48K USD |
Valuation Analysis
Below Book Valuation: The market values Hadasit Bio-Holdings Ltd's assets below their book value (0.04 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Hadasit Bio-Holdings Ltd's assets decreased by 79.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Hadasit Bio-Holdings Ltd (2012–2023)
The table below shows the annual total assets of Hadasit Bio-Holdings Ltd from 2012 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | $8.06 Million | -79.30% |
| 2022-12-31 | $38.95 Million | -41.35% |
| 2021-12-31 | $66.41 Million | +60.50% |
| 2020-12-31 | $41.38 Million | +339.65% |
| 2019-12-31 | $9.41 Million | -73.36% |
| 2018-12-31 | $35.34 Million | -48.49% |
| 2017-12-31 | $68.60 Million | -1.23% |
| 2016-12-31 | $69.46 Million | +1.23% |
| 2015-12-31 | $68.61 Million | +111.64% |
| 2014-12-31 | $32.42 Million | -6.73% |
| 2013-12-31 | $34.76 Million | -19.52% |
| 2012-12-31 | $43.19 Million | -- |